OncoLog: M. D. Anderson's report to physicians about advances in cancer care and research.

Rule

From OncoLog, March 2006, Vol. 51, No. 3

50 Years of OncoLog

by Martha Morrison

For 50 years, OncoLog has been bringing community physicians news about M. D. Anderson Cancer Center’s latest contributions to the war on cancer. Established in 1956, OncoLog was at first simply called News Letter. The institution’s first and only newsletter at the time, it provided a wide range of information, including news about cancer research conducted around the world, conference announcements, grant awards, and profiles of faculty.

Since then, OncoLog has evolved into a monthly publication that arms community physicians with news of the cutting-edge cancer research and innovative medicine practiced at M. D. Anderson. OncoLog shares news about clinical trials, promising translational research in our laboratories and clinics, and state-of-the-art treatments, and it provides a patient information page about cancer basics that doctors can share with their patients.

In the past 50 years, OncoLog has undergone a name change and several redesigns. It has chronicled M. D. Anderson’s advances, ranging from the use of the cryostat in diagnosing cancer (1957) to the design of what is now the world’s largest ambulatory treatment center for outpatient chemotherapy administration at M. D. Anderson (1988). What began as an informal quarterly newsletter is now a respected professional resource that reaches 33,000 physicians in the United States and around the world.

In 2003, OncoLog became available online and is among the most visited pages on M. D. Anderson’s Web site, averaging 840 visits a day, with 13% of site visitors living abroad. Online, it has also become a valuable resource for a wider lay audience looking for more sophisticated, in-depth information about cancer. A Spanish version of the publication is also available online to serve the increasing number of Spanish-speaking physicians.

Under the leadership of a new editorial board steered by Dr. Michael Fisch, medical director of M. D. Anderson’s Community Clinical Oncology Program, and Lyle Green, vice-president of Physician Relations, OncoLog will continue to update the medical community on how M. D. Anderson is translating emerging knowledge into improved treatments.

For more information on this topic or for questions about M. D. Anderson’s treatments, programs, or services, call askMDAnderson at (877) MDA-6789.

TopTOP

Home/Current Issue | Previous Issues | Articles by Topic | Patient Education
About Oncolog | Contact OncoLog
Sign Up for E-mail Alerts

©2008 The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd., Houston, TX 77030
1-877-MDA-6789 (USA) / 1-713-792-3245  
 Patient Referral    Legal Statements    Privacy Policy